The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran
Hypertension (HTN) is an important risk factor for cardiovascular disease (CVD) mortality and morbidity among Iranians. The present study aimed to estimate the prevalence of pre-HTN and HTN and some of its related factors in south of Iran. This cross-sectional survey was conducted on the data of the...
Saved in:
Published in | Journal of human hypertension Vol. 35; no. 3; pp. 257 - 264 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.03.2021
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hypertension (HTN) is an important risk factor for cardiovascular disease (CVD) mortality and morbidity among Iranians. The present study aimed to estimate the prevalence of pre-HTN and HTN and some of its related factors in south of Iran. This cross-sectional survey was conducted on the data of the Persian cohort study in Kherameh. The participants consisted of 10,663 people aged 40–70 years. HTN was defined as either systolic/diastolic blood pressure (SBP/DBP) ≥140/90 mmHg or taking medications. Pre-HTN was defined as SBP = 120–139 mmHg and/or DBP = 80–89 mmHg. The logistic regression method was used to identify the factors associated with pre-HTN and HTN. The age-standardized prevalence rate (ASPR) of pre-HTN was 19.66% (95% CI: 19.45–19.86%) and 18.59% (95% CI: 18.36–18.83%) in males and females, respectively. Also, the ASPR of HTN was 21.44 (95% CI: 21.22–21.65%) in males and 33.53% (95% CI: 33.22–33.85%) in females. Male gender, old age, being unemployed, low education level, high body mass index (BMI), no smoking, diabetes, cerebro-cardiovascular disease, suffering from another chronic disease, family history of CVD, and negative family history of cancer and other chronic diseases were independently associated with pre-HTN (
p
< 0.05). All variables, except for gender, smoking, and family history of cancer, were significantly associated with HTN. Drug abuse was also correlated to HTN (
p
< 0.05). This study revealed the increased prevalence of HTN in rural and urban areas. Therefore, the health system needs to develop strategies to raise the accessibility of screening and diagnostic services. |
---|---|
AbstractList | Hypertension (HTN) is an important risk factor for cardiovascular disease (CVD) mortality and morbidity among Iranians. The present study aimed to estimate the prevalence of pre-HTN and HTN and some of its related factors in south of Iran. This cross-sectional survey was conducted on the data of the Persian cohort study in Kherameh. The participants consisted of 10,663 people aged 40–70 years. HTN was defined as either systolic/diastolic blood pressure (SBP/DBP) ≥140/90 mmHg or taking medications. Pre-HTN was defined as SBP = 120–139 mmHg and/or DBP = 80–89 mmHg. The logistic regression method was used to identify the factors associated with pre-HTN and HTN. The age-standardized prevalence rate (ASPR) of pre-HTN was 19.66% (95% CI: 19.45–19.86%) and 18.59% (95% CI: 18.36–18.83%) in males and females, respectively. Also, the ASPR of HTN was 21.44 (95% CI: 21.22–21.65%) in males and 33.53% (95% CI: 33.22–33.85%) in females. Male gender, old age, being unemployed, low education level, high body mass index (BMI), no smoking, diabetes, cerebro-cardiovascular disease, suffering from another chronic disease, family history of CVD, and negative family history of cancer and other chronic diseases were independently associated with pre-HTN (p < 0.05). All variables, except for gender, smoking, and family history of cancer, were significantly associated with HTN. Drug abuse was also correlated to HTN (p < 0.05). This study revealed the increased prevalence of HTN in rural and urban areas. Therefore, the health system needs to develop strategies to raise the accessibility of screening and diagnostic services. Hypertension (HTN) is an important risk factor for cardiovascular disease (CVD) mortality and morbidity among Iranians. The present study aimed to estimate the prevalence of pre-HTN and HTN and some of its related factors in south of Iran. This cross-sectional survey was conducted on the data of the Persian cohort study in Kherameh. The participants consisted of 10,663 people aged 40-70 years. HTN was defined as either systolic/diastolic blood pressure (SBP/DBP) [greater than or equal to]140/90 mmHg or taking medications. Pre-HTN was defined as SBP = 120-139 mmHg and/or DBP = 80-89 mmHg. The logistic regression method was used to identify the factors associated with pre-HTN and HTN. The age-standardized prevalence rate (ASPR) of pre-HTN was 19.66% (95% CI: 19.45-19.86%) and 18.59% (95% CI: 18.36-18.83%) in males and females, respectively. Also, the ASPR of HTN was 21.44 (95% CI: 21.22-21.65%) in males and 33.53% (95% CI: 33.22-33.85%) in females. Male gender, old age, being unemployed, low education level, high body mass index (BMI), no smoking, diabetes, cerebro-cardiovascular disease, suffering from another chronic disease, family history of CVD, and negative family history of cancer and other chronic diseases were independently associated with pre-HTN (p < 0.05). All variables, except for gender, smoking, and family history of cancer, were significantly associated with HTN. Drug abuse was also correlated to HTN (p < 0.05). This study revealed the increased prevalence of HTN in rural and urban areas. Therefore, the health system needs to develop strategies to raise the accessibility of screening and diagnostic services. Hypertension (HTN) is an important risk factor for cardiovascular disease (CVD) mortality and morbidity among Iranians. The present study aimed to estimate the prevalence of pre-HTN and HTN and some of its related factors in south of Iran. This cross-sectional survey was conducted on the data of the Persian cohort study in Kherameh. The participants consisted of 10,663 people aged 40–70 years. HTN was defined as either systolic/diastolic blood pressure (SBP/DBP) ≥140/90 mmHg or taking medications. Pre-HTN was defined as SBP = 120–139 mmHg and/or DBP = 80–89 mmHg. The logistic regression method was used to identify the factors associated with pre-HTN and HTN. The age-standardized prevalence rate (ASPR) of pre-HTN was 19.66% (95% CI: 19.45–19.86%) and 18.59% (95% CI: 18.36–18.83%) in males and females, respectively. Also, the ASPR of HTN was 21.44 (95% CI: 21.22–21.65%) in males and 33.53% (95% CI: 33.22–33.85%) in females. Male gender, old age, being unemployed, low education level, high body mass index (BMI), no smoking, diabetes, cerebro-cardiovascular disease, suffering from another chronic disease, family history of CVD, and negative family history of cancer and other chronic diseases were independently associated with pre-HTN ( p < 0.05). All variables, except for gender, smoking, and family history of cancer, were significantly associated with HTN. Drug abuse was also correlated to HTN ( p < 0.05). This study revealed the increased prevalence of HTN in rural and urban areas. Therefore, the health system needs to develop strategies to raise the accessibility of screening and diagnostic services. |
Audience | Academic |
Author | Sadeghi, Seyed Ebrahim Jafari, Fatemeh Rezaianzadeh, Abbas Rahimikazerooni, Salar |
Author_xml | – sequence: 1 givenname: Abbas surname: Rezaianzadeh fullname: Rezaianzadeh, Abbas organization: Colorectal Research Center, SUMS – sequence: 2 givenname: Fatemeh orcidid: 0000-0003-2392-4516 surname: Jafari fullname: Jafari, Fatemeh email: m.jafarii4319@gmail.com organization: MSc Candidate of Epidemiology in Shiraz University of Medical Sciences – sequence: 3 givenname: Seyed Ebrahim surname: Sadeghi fullname: Sadeghi, Seyed Ebrahim organization: Anesthesiology Department, SUMS – sequence: 4 givenname: Salar surname: Rahimikazerooni fullname: Rahimikazerooni, Salar organization: Colorectal Research Center, SUMS |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32203076$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kstu1TAQhi1URE8LD8AGRUJCLEjxJbZPuqsqLhWV2JS15WNPmlSJHWwH6bwJj4tNCuUgkBfxzHzzJzP5T9CR8w4Qek7wGcFs-zY2hElSY4przBiut4_QhjRS1JxTeYQ2uOW4bmmDj9FJjHcYl-L2CTpmlGKGpdig7zc9VHOAb3oEZ6DSzpbQDib5ECvflaju9zOEBC4O3v1EDhKDqz71EPQEfWV870OqYlrs_rzS1eznZdSpYDsdwa6VKocEvxGCVVkneheLSPRL6ssrr4J2T9HjTo8Rnt0_T9GX9-9uLj_W158_XF1eXNemkTjVhkiQwraW2FaCFZILagTPV9pJ3QkpLaaWcdo2IKjghnFLZJvHlztMWsJO0etVdw7-6wIxqWmIBsZRO_BLVJRtaVYlzTajL_9C7_wSXP46RXneZyOblj5Qt3mlanCdT0GbIqouBOeSCNqwTJ39g8rHwjSY_Ju7IecPGl790dCDHlMf_biU1cZDkKygCT7GAJ2awzDpsFcEq2IbtdpGZduoYhtVJntxP9mym8D-7vjlkwzQFYi55G4hPIz-f9Uf-0_MTw |
CitedBy_id | crossref_primary_10_1080_00015385_2022_2045753 crossref_primary_10_1002_fsn3_3164 crossref_primary_10_1136_bmjopen_2022_062328 crossref_primary_10_52547_ijhehp_9_1_5 crossref_primary_10_1155_2021_9672994 crossref_primary_10_1186_s12872_022_02683_w crossref_primary_10_1016_j_numecd_2023_06_009 crossref_primary_10_1038_s41598_024_61846_1 crossref_primary_10_1371_journal_pone_0295270 crossref_primary_10_1002_hsr2_1601 |
Cites_doi | 10.5812/ijem.59706 10.4103/2224-3151.122937 10.1038/jhh.2013.22 10.1161/CIRCULATIONAHA.110.958769 10.1097/HJH.0000000000000428 10.1155/2014/564679 10.1038/hr.2011.99 10.1371/journal.pone.0170238 10.1186/2251-6581-12-11 10.18203/2394-6040.ijcmph20191401 10.1093/aje/kwx314 10.2188/jea.JE20110132 10.1007/s12098-011-0663-y 10.1097/HJH.0b013e32833a38f2 10.1038/s41371-017-0010-5 10.26719/emhj.19.042 10.1186/1471-2261-13-101 10.1186/s12889-018-6216-9 10.3390/ijerph15071394 10.4178/epih.e2018020 10.3402/gha.v7.23286 10.1371/journal.pone.0195340 10.1097/HJH.0b013e3283613053 10.1161/HYPERTENSIONAHA.107.087338 10.1016/S0140-6736(10)62036-3 10.1093/eurheartj/ehy339 10.1371/journal.pone.0125210 10.1093/ajh/hps013 10.1016/j.jacc.2011.03.042 10.1161/HYPERTENSIONAHA.113.01374 10.1007/s40292-013-0035-y 10.3390/ijerph13010082 10.1155/2015/897070 10.1159/000323164 10.1001/jama.287.8.1003 10.15171/jcvtr.2016.35 10.1016/j.jhealeco.2009.10.003 10.1053/j.ajkd.2009.06.044 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer Nature Limited 2020 COPYRIGHT 2021 Nature Publishing Group The Author(s), under exclusive licence to Springer Nature Limited 2020. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Nature Limited 2020 – notice: COPYRIGHT 2021 Nature Publishing Group – notice: The Author(s), under exclusive licence to Springer Nature Limited 2020. |
DBID | NPM AAYXX CITATION 3V. 7T5 7X7 7XB 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1038/s41371-020-0330-8 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health Statistics |
EISSN | 1476-5527 |
EndPage | 264 |
ExternalDocumentID | A655716243 10_1038_s41371_020_0330_8 32203076 |
Genre | Journal Article |
GeographicLocations | Iran |
GeographicLocations_xml | – name: Iran |
GroupedDBID | --- -Q- 0R~ 29K 2WC 36B 39C 3V. 4.4 406 53G 5GY 5RE 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 A8Z AACDK AANZL AASML AATNV AAWBL AAZLF ABAKF ABAWZ ABCQX ABDBF ABJNI ABLJU ABOCM ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACZOJ ADBBV ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFSHS AGAYW AGEZK AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AXYYD B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 D-I DIK DNIVK DPUIP DU5 E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESTFP ESX F5P FDQFY FERAY FIGPU FIZPM FSGXE FYUFA HCIFZ HMCUK HZ~ IAO IHR IHW INH INR ITC IWAJR JSO JZLTJ KQ8 L7B M1P M7P NAO NQJWS O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT SNX SNYQT SOHCF SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UKHRP W2D YYP ZXP ~8M AAYZH NPM AAYXX CITATION AADWK AAYFA AAYJO ABGIJ ACBMV ACBRV ACBYP ACIGE ACTTH ACVWB ADMDM ADQMX ADYYL AEDAW AEFTE AFNRJ AGGBP AJCLW AJDOV AMRJV NYICJ 7T5 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ H94 K9. LK8 PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c470t-c17e76d9d1d97ed67562c657ed2f7af677d02d35294e6265c35d1792037b01913 |
IEDL.DBID | BENPR |
ISSN | 0950-9240 |
IngestDate | Fri Oct 25 04:41:47 EDT 2024 Thu Oct 10 20:10:50 EDT 2024 Fri Feb 23 00:04:48 EST 2024 Fri Feb 02 04:22:44 EST 2024 Tue Aug 20 22:03:46 EDT 2024 Thu Sep 26 15:30:49 EDT 2024 Wed Oct 16 00:43:23 EDT 2024 Fri Oct 11 20:56:39 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c470t-c17e76d9d1d97ed67562c657ed2f7af677d02d35294e6265c35d1792037b01913 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-2392-4516 |
PMID | 32203076 |
PQID | 2503047492 |
PQPubID | 35973 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2382675148 proquest_journals_2503047492 gale_infotracmisc_A655716243 gale_infotracacademiconefile_A655716243 gale_healthsolutions_A655716243 crossref_primary_10_1038_s41371_020_0330_8 pubmed_primary_32203076 springer_journals_10_1038_s41371_020_0330_8 |
PublicationCentury | 2000 |
PublicationDate | 2021-03-01 |
PublicationDateYYYYMMDD | 2021-03-01 |
PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Journal of human hypertension |
PublicationTitleAbbrev | J Hum Hypertens |
PublicationTitleAlternate | J Hum Hypertens |
PublicationYear | 2021 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | NuwahaFMusinguziGPre-hypertension in Uganda: a cross-sectional studyBMC Cardiovasc Disord201313242289453833647 GandomkarAPoustchiHMalekzadehFMalekzadehMMMoiniMMoghadamiMPrevalence, awareness, treatment, control, and correlates of hypertension in the Pars Cohort StudyArch Iran Med2018213354330113854 SankohOSharrowDHerbstKWhiteson KabudulaCAlamNKantSThe INDEPTH standard population for low-and middle-income countries, 2013Glob Health Action201472328624679543 Krishnan A, Garg R, Kahandaliyanage A, editors. Hypertension in the South-East Asia region: an overview. Regional Health Forum; 2013. YangGMaYWangSSuYRaoWFuYPrevalence and correlates of prehypertension and hypertension among adults in Northeastern China: a cross-sectional studyInt J Environ Res Public Health20161382 AbebeSMBerhaneYWorkuAGetachewAPrevalence and associated factors of hypertension: a crossectional community based study in Northwest EthiopiaPLoS ONE201510e0125210259093824409323 BasuSMillettCSocial epidemiology of hypertension in middle-income countries: determinants of prevalence, diagnosis, treatment, and control in the WHO SAGE studyHypertension20136218261:CAS:528:DC%2BC3sXptlKntLs%3D23670299 PanesarSChaturvediSSainiNAvasthiRSinghAPrevalence and predictors of hypertension among residents aged 20–59 years of a slum-resettlement colony in Delhi, IndiaWHO South-East Asia J Public Health2013283728612764 SinghMKotwalAMittalCBabuSRBhartiSRamCVSPrevalence and correlates of hypertension in a semi-rural population of Southern IndiaJ Hum Hypertens2018326674 KowlessurSHuZHeecharanJWangJDaiJTuomilehtoJOPredictors of hypertension in mauritians with normotension and prehypertension at baseline: a Cohort StudyInt J Environ Res Public Health20181513946068703 WilliamsBManciaGSpieringWAgabiti RoseiEAziziMBurnierM2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)Eur Heart J2018393021104 PakzadBAkbariMBaberiFPrevalence, awareness, treatment, and control of hypertension in an Isfahan State Institution SampleJ Tehran Univ Heart Cent2018136572 HuangJZhangWLiXZhouJGaoYCaiYAnalysis of the prevalence and risk factors of hypertension in the She population in Fujian, ChinaKidney Blood Press Res20113469741:CAS:528:DC%2BC3MXjtVShsbs%3D21212687 KumarJDeshmukhPRGargBSPrevalence and correlates of sustained hypertension in adolescents of rural Wardha, central IndiaIndian J Pediatr20127912061222203427 GhaffariSPourafkariLTajlilASahebihaghMHMohammadpooraslATabriziJSThe prevalence, awareness and control rate of hypertension among elderly in northwest of IranJ Cardiovasc Thorac Res2016817682282104745304101 Organization WHO.Global database on Body Mass Index: BMI Classification, 20062015Geneva, SwitzerlandWorld Health Organization LamCSChengSChoongKLarsonMGMurabitoJMNewton-ChehCInfluence of sex and hormone status on circulating natriuretic peptidesJ Am Coll Cardiol201158618261:CAS:528:DC%2BC3MXhtFGns7%2FK217984253170816 AldiabAShubairMMAl-ZahraniJMAldossariKKAl-GhamdiSHousehMPrevalence of hypertension and prehypertension and its associated cardioembolic risk factors; a population based cross-sectional study in Alkharj, Saudi ArabiaBMC Public Health201818304974256267095 BarengoNAntikainenRKastarinenMLaatikainenTTuomilehtoJThe effects of control of systolic and diastolic hypertension on cardiovascular and all-cause mortality in a community-based population cohortJ Hum Hypertens201327693971:STN:280:DC%2BC3svotFemtQ%3D%3D23514844 HuLHuangXYouCLiJHongKLiPPrevalence and risk factors of prehypertension and hypertension in Southern ChinaPLoS ONE201712e0170238280954715240940 RaniBPalRJhaSPuniaASinghSPrevalence and risk factors associated with prehypertension and hypertension among attendants of patients at a rural tertiary care institute of HaryanaInt J Community Med Public Health20196165764 PeymaniPHeydariSTAhmadiSMSarikhaniYJoulaeiHMoghadamiMThe prevalence of high blood pressure and its relationship with anthropometric indicators; a population based study in Fars Province, IR IranInt Cardiovasc Res J20126405 EghbaliMKhosraviAFeiziAMansouriAMahakiBSarrafzadeganNPrevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in IranEpidemiol Health201840e2018020298074086060339 SepanlouSGKamangarFPoustchiHMalekzadehRReducing the burden of chronic diseases: a neglected agenda in Iranian health care system, requiring a plan for actionArch Iran Med2010133405020597569 CutlerDMLleras-MuneyAUnderstanding differences in health behaviors by educationJ Health Econ20102912819963292 JatoiNAJerrard-DunnePFeelyJMahmudAImpact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertensionHypertension20074998151:CAS:528:DC%2BD2sXktFagsbc%3D17372029 DanaeiGFinucaneMMLinJKSinghGMPaciorekCJCowanMJNational, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5· 4 million participantsLancet20113775687721295844 ShahbazianHLatifiSMJalaliMTShahbazianHAmaniRNikhooAMetabolic syndrome and its correlated factors in an urban population in South West of IranJ Diabetes Metab Disord20131211234975063598198 KhosraviAEmamianMHShariatiMHashemiHFotouhiAThe prevalence of pre-hypertension and hypertension in an Iranian urban populationHigh Blood Press Cardiovasc Prev2014211273524272061 Katibeh M, Sanjari Moghaddam A, Yaseri M, Neupane D, Kallestrup P, Ahmadieh H. Hypertension and associated factors in the Islamic Republic of Iran: a population-based study. East Mediterr Health J. 2019;25. JSDdCostaBarcellosFCSclowitzMLSclowitzIKTCastanheiraMOlintoMTAHypertension prevalence and its associated risk factors in adults: a population-based study in PelotasArquivos Bras Cardiol200788549 VasanRSBeiserASeshadriSLarsonMGKannelWBD’AgostinoRBResidual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart StudyJAMA200228710031011866648 MalekzadehMMEtemadiAKamangarFKhademiHGolozarAIslamiFPrevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult populationJ Hypertens20133113641:CAS:528:DC%2BC3sXhtVyksb%2FE236733483766446 TianSDongG-HWangDLiuM-MLinQMengX-JFactors associated with prevalence, awareness, treatment and control of hypertension in urban adults from 33 communities in China: the CHPSNE StudyHypertens Res201134108721775998 Zinat Motlagh SF, Chaman R, Ghafari SR, Parisay Z, Golabi MR, Eslami AA, et al. Knowledge, treatment, control, and risk factors for hypertension among adults in Southern Iran. Int J Hypertension. 2015. https://doi.org/10.1155/2015/897070. EbrahimiMMansourniaMAHaghdoostAAAbazariAAlaeddiniFMirzazadehASocial disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases, 2006J Hypertens201028162091:CAS:528:DC%2BC3cXptVCnu7o%3D20647858 WangJSunWWellsGALiZLiTWuJDifferences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People’s Republic of China: a cross-sectional studyPLoS ONE201813e0195340296213285886571 BelachewATewabeTMiskirYMeleseEWubetEAlemuSPrevalence and associated factors of hypertension among adult patients in Felege–Hiwot Comprehensive Referral Hospitals, northwest, Ethiopia: a cross-sectional studyBMC Res Notes201811305266866288930 El Bcheraoui C, Memish ZA, Tuffaha M, Daoud F, Robinson M, Jaber S, et al. Hypertension and its associated risk factors in the kingdom of saudi arabia, 2013: a national survey. Int J Hypertens. 2014. https://doi.org/10.1155/2014/564679. GuptaRDeedwaniaPCAchariVBhansaliAGuptaBKGuptaANormotension, prehypertension, and hypertension in urban middle-class subjects in India: prevalence, awareness, treatment, and controlAm J Hypertens2012268394 LengBJinYLiGChenLJinNSocioeconomic status and hypertension: a meta-analysisJ Hypertens20153322191:CAS:528:DC%2BC2cXitFaqur%2FJ25479029 PoustchiHEghtesadSKamangarFEtemadiAKeshtkarA-AHekmatdoostAProspective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and designAm J Epidemiol20181876475529145581 Taherian R, Jalali-Farahani S, Karimi M, Amiri P, Maghsoudi E, Mirmiran P, et al. Factors associated with pre-hypertension among Tehranian adults: a novel application of structural equation models. Int J Endocrinol Metab. 2018;16:e59706. ChaSHParkHSChoHJSocioeconomic disparities in prevalence, treatment, and control of hypertension in middle-aged KoreansJ Epidemiol20122242532227852473798637 KheradmandMEnayatiARafieiAMoosazadehMPopulation based cohort studies in Iran: a review articleJ Mazandaran Univ Med Sci20152517185 MittalBVSinghAKHypertension in the developing world: challenges and opportunitiesAm J Kidney Dis201055590819962803 SimonettiGDSchwertzRKlettMHoffmannGFSchaeferFWühlEDeterminants of blood pressure in preschool children: the role of parental smokingCirculation2011123292821220729 B Pakzad (330_CR30) 2018; 13 DM Cutler (330_CR43) 2010; 29 330_CR44 330_CR1 J Huang (330_CR42) 2011; 34 Organization WHO. (330_CR18) 2015 CS Lam (330_CR34) 2011; 58 S Kowlessur (330_CR10) 2018; 15 R Gupta (330_CR19) 2012; 26 B Rani (330_CR24) 2019; 6 J Wang (330_CR3) 2018; 13 A Gandomkar (330_CR32) 2018; 21 H Poustchi (330_CR16) 2018; 187 M Ebrahimi (330_CR7) 2010; 28 MM Malekzadeh (330_CR28) 2013; 31 A Aldiab (330_CR12) 2018; 18 A Belachew (330_CR4) 2018; 11 RS Vasan (330_CR36) 2002; 287 N Barengo (330_CR22) 2013; 27 F Nuwaha (330_CR33) 2013; 13 BV Mittal (330_CR11) 2010; 55 L Hu (330_CR23) 2017; 12 G Yang (330_CR31) 2016; 13 S Tian (330_CR35) 2011; 34 330_CR13 GD Simonetti (330_CR47) 2011; 123 S Ghaffari (330_CR8) 2016; 8 SM Abebe (330_CR14) 2015; 10 M Eghbali (330_CR6) 2018; 40 B Leng (330_CR40) 2015; 33 M Singh (330_CR26) 2018; 32 B Williams (330_CR20) 2018; 39 P Peymani (330_CR27) 2012; 6 M Kheradmand (330_CR15) 2015; 25 J Kumar (330_CR39) 2012; 79 S Basu (330_CR38) 2013; 62 S Panesar (330_CR46) 2013; 2 O Sankoh (330_CR21) 2014; 7 SH Cha (330_CR41) 2012; 22 A Khosravi (330_CR9) 2014; 21 330_CR29 Costa JSDd (330_CR37) 2007; 88 G Danaei (330_CR5) 2011; 377 SG Sepanlou (330_CR2) 2010; 13 H Shahbazian (330_CR17) 2013; 12 NA Jatoi (330_CR45) 2007; 49 330_CR25 |
References_xml | – ident: 330_CR25 doi: 10.5812/ijem.59706 – volume: 2 start-page: 83 year: 2013 ident: 330_CR46 publication-title: WHO South-East Asia J Public Health doi: 10.4103/2224-3151.122937 contributor: fullname: S Panesar – volume: 27 start-page: 693 year: 2013 ident: 330_CR22 publication-title: J Hum Hypertens doi: 10.1038/jhh.2013.22 contributor: fullname: N Barengo – volume: 123 start-page: 292 year: 2011 ident: 330_CR47 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.110.958769 contributor: fullname: GD Simonetti – volume: 33 start-page: 221 year: 2015 ident: 330_CR40 publication-title: J Hypertens doi: 10.1097/HJH.0000000000000428 contributor: fullname: B Leng – ident: 330_CR44 doi: 10.1155/2014/564679 – volume: 34 start-page: 1087 year: 2011 ident: 330_CR35 publication-title: Hypertens Res doi: 10.1038/hr.2011.99 contributor: fullname: S Tian – volume: 12 start-page: e0170238 year: 2017 ident: 330_CR23 publication-title: PLoS ONE doi: 10.1371/journal.pone.0170238 contributor: fullname: L Hu – volume: 12 start-page: 11 year: 2013 ident: 330_CR17 publication-title: J Diabetes Metab Disord doi: 10.1186/2251-6581-12-11 contributor: fullname: H Shahbazian – volume: 6 start-page: 1657 year: 2019 ident: 330_CR24 publication-title: Int J Community Med Public Health doi: 10.18203/2394-6040.ijcmph20191401 contributor: fullname: B Rani – volume: 187 start-page: 647 year: 2018 ident: 330_CR16 publication-title: Am J Epidemiol doi: 10.1093/aje/kwx314 contributor: fullname: H Poustchi – volume: 22 start-page: 425 year: 2012 ident: 330_CR41 publication-title: J Epidemiol doi: 10.2188/jea.JE20110132 contributor: fullname: SH Cha – volume: 79 start-page: 1206 year: 2012 ident: 330_CR39 publication-title: Indian J Pediatr doi: 10.1007/s12098-011-0663-y contributor: fullname: J Kumar – volume: 28 start-page: 1620 year: 2010 ident: 330_CR7 publication-title: J Hypertens doi: 10.1097/HJH.0b013e32833a38f2 contributor: fullname: M Ebrahimi – volume: 32 start-page: 66 year: 2018 ident: 330_CR26 publication-title: J Hum Hypertens doi: 10.1038/s41371-017-0010-5 contributor: fullname: M Singh – ident: 330_CR29 doi: 10.26719/emhj.19.042 – ident: 330_CR13 – volume: 13 year: 2013 ident: 330_CR33 publication-title: BMC Cardiovasc Disord doi: 10.1186/1471-2261-13-101 contributor: fullname: F Nuwaha – volume: 18 year: 2018 ident: 330_CR12 publication-title: BMC Public Health doi: 10.1186/s12889-018-6216-9 contributor: fullname: A Aldiab – volume: 15 start-page: 1394 year: 2018 ident: 330_CR10 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph15071394 contributor: fullname: S Kowlessur – volume: 40 start-page: e2018020 year: 2018 ident: 330_CR6 publication-title: Epidemiol Health doi: 10.4178/epih.e2018020 contributor: fullname: M Eghbali – volume: 7 start-page: 23286 year: 2014 ident: 330_CR21 publication-title: Glob Health Action doi: 10.3402/gha.v7.23286 contributor: fullname: O Sankoh – volume: 13 start-page: e0195340 year: 2018 ident: 330_CR3 publication-title: PLoS ONE doi: 10.1371/journal.pone.0195340 contributor: fullname: J Wang – volume: 31 start-page: 1364 year: 2013 ident: 330_CR28 publication-title: J Hypertens doi: 10.1097/HJH.0b013e3283613053 contributor: fullname: MM Malekzadeh – volume: 11 year: 2018 ident: 330_CR4 publication-title: BMC Res Notes contributor: fullname: A Belachew – volume: 49 start-page: 981 year: 2007 ident: 330_CR45 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.107.087338 contributor: fullname: NA Jatoi – volume: 6 start-page: 40 year: 2012 ident: 330_CR27 publication-title: Int Cardiovasc Res J contributor: fullname: P Peymani – volume: 88 start-page: 54 year: 2007 ident: 330_CR37 publication-title: Arquivos Bras Cardiol contributor: fullname: Costa JSDd – volume: 377 start-page: 568 year: 2011 ident: 330_CR5 publication-title: Lancet doi: 10.1016/S0140-6736(10)62036-3 contributor: fullname: G Danaei – volume: 13 start-page: 340 year: 2010 ident: 330_CR2 publication-title: Arch Iran Med contributor: fullname: SG Sepanlou – volume: 13 start-page: 65 year: 2018 ident: 330_CR30 publication-title: J Tehran Univ Heart Cent contributor: fullname: B Pakzad – volume: 39 start-page: 3021 year: 2018 ident: 330_CR20 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy339 contributor: fullname: B Williams – volume: 21 start-page: 335 year: 2018 ident: 330_CR32 publication-title: Arch Iran Med contributor: fullname: A Gandomkar – volume: 10 start-page: e0125210 year: 2015 ident: 330_CR14 publication-title: PLoS ONE doi: 10.1371/journal.pone.0125210 contributor: fullname: SM Abebe – volume: 26 start-page: 83 year: 2012 ident: 330_CR19 publication-title: Am J Hypertens doi: 10.1093/ajh/hps013 contributor: fullname: R Gupta – volume-title: Global database on Body Mass Index: BMI Classification, 2006 year: 2015 ident: 330_CR18 contributor: fullname: Organization WHO. – volume: 58 start-page: 618 year: 2011 ident: 330_CR34 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2011.03.042 contributor: fullname: CS Lam – volume: 62 start-page: 18 year: 2013 ident: 330_CR38 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.113.01374 contributor: fullname: S Basu – volume: 21 start-page: 127 year: 2014 ident: 330_CR9 publication-title: High Blood Press Cardiovasc Prev doi: 10.1007/s40292-013-0035-y contributor: fullname: A Khosravi – volume: 13 start-page: 82 year: 2016 ident: 330_CR31 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph13010082 contributor: fullname: G Yang – ident: 330_CR1 doi: 10.1155/2015/897070 – volume: 34 start-page: 69 year: 2011 ident: 330_CR42 publication-title: Kidney Blood Press Res doi: 10.1159/000323164 contributor: fullname: J Huang – volume: 287 start-page: 1003 year: 2002 ident: 330_CR36 publication-title: JAMA doi: 10.1001/jama.287.8.1003 contributor: fullname: RS Vasan – volume: 8 start-page: 176 year: 2016 ident: 330_CR8 publication-title: J Cardiovasc Thorac Res doi: 10.15171/jcvtr.2016.35 contributor: fullname: S Ghaffari – volume: 25 start-page: 171 year: 2015 ident: 330_CR15 publication-title: J Mazandaran Univ Med Sci contributor: fullname: M Kheradmand – volume: 29 start-page: 1 year: 2010 ident: 330_CR43 publication-title: J Health Econ doi: 10.1016/j.jhealeco.2009.10.003 contributor: fullname: DM Cutler – volume: 55 start-page: 590 year: 2010 ident: 330_CR11 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2009.06.044 contributor: fullname: BV Mittal |
SSID | ssj0014768 |
Score | 2.4224083 |
Snippet | Hypertension (HTN) is an important risk factor for cardiovascular disease (CVD) mortality and morbidity among Iranians. The present study aimed to estimate the... |
SourceID | proquest gale crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 257 |
SubjectTerms | 692/499 692/699/75/243 Blood pressure Body mass index Cardiovascular disease Cardiovascular diseases Chronic illnesses Cohort analysis Demographic aspects Diabetes mellitus Drug abuse Epidemiology Family medical history Gender Health Administration Hypertension Males Medicine Medicine & Public Health Morbidity Population studies Population-based studies Public Health Risk factors Smoking Statistics |
Title | The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran |
URI | https://link.springer.com/article/10.1038/s41371-020-0330-8 https://www.ncbi.nlm.nih.gov/pubmed/32203076 https://www.proquest.com/docview/2503047492 https://search.proquest.com/docview/2382675148 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9QwDLfYTUK8IP6vMEaQkJCAaGnSNi0vaKBNA8SEEJPuLeolqcYDbWm778LHxU57HZ0Eb5eLr03Psf1z7dgALxLlBele7spCc7R4ipdeCL4pN1VqCymcC1m-Z9npefJpna6nF279lFa51YlBUbvG0jvyQzTVFCFKCvmu_cWpaxRFV6cWGjuwK9FTkCvYfX989vXbHEdIdDgMhzhCcPQ05rimyg97VN8aXWl0nwQ69TxfWKbr-vkvA3UtYhoM0ckduD0hSHY0svwu3PD1Pbj5ZYqR34ffyHnWdlTGm6SWlbWjIU5TYx3WVDTiF-h_diF7vakDyeKLHzX7TAezfvoLRi10u4GFOrRvWcnaueUXIxPoxhmGw1i8QWTB2gDie7pITw366JYf0SQ-gPOT4-8fTvnUf4HbRIuB21h7nbnCxa7Q3qFrkUmbpfhRVrqsMq2dkA4RXJF49ItSq1KH8i2F0htEjrF6CKu6qf0eMJdbm1ZKI_6oElu5Iil9LDYOlav0sfURvNr-96Ydy2yYEB5XuRkZZZBRhhhl8gieEXfMeFJ0FlFzlKUpFcRKVAQvAwUJ6dCVtpzOGuBiqNzVgnJ_QYnCZZfT2x1gJuHuzdVWjOD5PE2_pIS12jeXSKPQb9OIRnG1j8adMz8Y6lBSrVkEr7db6eri_3zqx_9fyhO4JSndJqTH7cNq6C79U8RLw-YAdvRaH0yi8QeicxI- |
link.rule.ids | 315,783,787,12070,21402,27938,27939,31733,31734,33758,33759,43324,43819,74081,74638 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSMAF8W6gpUZCQgKsOrETJ1xQhai29HFqpb1Zju2oHJqEJP0v_FxmnGxKKtHbej2bODuex5cZzxDyQQrPUfcyZwrFwOIJZjznrDRlldoi4c6FLN-zbHUhf67T9fTCrZ_SKjc6MShq11h8R74PphojRLJIvrW_GXaNwujq1ELjPnmAdbiwdr5az4ArliochQMvgjPAGXNUU-T7PShvBUAawBMHSM_yhV26rZ3_MU-34qXBDB0-JU8m_5EejAx_Ru75-jl5eDpFyF-QP8B32nZYxBtllpra4RCmsa0ObSocsUtAn13IXW_qQLL44ldNj_FY1pW_pNhAtxtoqEL7lRrazg2_KBpAN85QGMb8C_gVtA0ufI8X6bE9H97yCAziS3Jx-OP8-4pN3ReYlYoPzMbKq8wVLnaF8g6ARZbYLIWPSaVMlSnleOLAfyukB1SUWpE6kO6EC1WC3xiLV2Srbmq_TajLrU0rocD7qKStXCGNj3npQLUmPrY-Ip82_71uxyIbOgTHRa5HRmlglEZG6Twie8gdPZ4TnQVUH2RpiuWwpIjIx0CBIjp0xprppAEsBotdLSh3FpQgWnY5vdkBehLtXt9sxIi8n6fxl5iuVvvmGmgEoDYFviis9vW4c-YHAw2KijWLyOfNVrq5-H-f-s3dS9kjj1bnpyf65Ojs-C15nGDiTUiU2yFbQ3ftd8FzGsp3QTz-Ap02EuI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db5UwtNGZLL4Yv8ecriYmJmpzCy0UfDGLerM5XXxwyX1rSlsyHwQE9l_2cz2ncJks0TdKD1A435zTcwh5JYXnKHuZM4VioPEEM55zVpqySm2RcOdClu9Zdnwuv2zSzZT_1E9plVuZGAS1ayz-I1-BqsYIkSySVTWlRXz_tP7Q_mbYQQojrVM7jdvkjpKg6IC21WZ2vmKpwrY4sCg4A59jjnCKfNWDIFfgVIMjxcG9Z_lCR92U1H-pqhux06CS1vfJvcmWpEcj8h-QW75-SHa_TdHyR-QKaIC2HRb0Rv6lpnY4hGlssUObCkfsAjzRLuSxN3UAWZz4WdNT3KL1y19QbKbbDTRUpH1PDW3n5l8UlaEbZygMY_4ObAzaBnO-x5v02KoPH3kCyvExOV9__vHxmE2dGJiVig_MxsqrzBUudoXyDpyMLLFZCodJpUyVKeV44sCWK6QHDym1InXA6QkXqgQbMhZPyE7d1H6PUJdbm1ZCgSVSSVu5Qhof89KBmE18bH1E3my_vW7Hghs6BMpFrkdEaUCURkTpPCKHiB097hmdmVUfZWmKpbGkiMjrAIHsOnTGmmnXASwGC18tIA8WkMBmdjm9pQA9sXmvr4kyIi_nabwSU9dq31wCjAAPToFdCqt9OlLO_GIgTVHIZhF5uyWl65v_8633_7-UQ7ILnKG_npydPiN3E8zBCTlzB2Rn6C79czCihvJF4I4_yPYXFw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+prevalence+and+predictors+of+pre-hypertension+and+hypertension+in+Kherameh+cohort+study%3A+a+population+based+study+on+10%2C663+persons+in+south+of+Iran&rft.jtitle=Journal+of+human+hypertension&rft.au=Rezaianzadeh%2C+Abbas&rft.au=Jafari%2C+Fatemeh&rft.au=Sadeghi%2C+Seyed+Ebrahim&rft.au=Rahimikazerooni%2C+Salar&rft.date=2021-03-01&rft.eissn=1476-5527&rft.volume=35&rft.issue=3&rft.spage=257&rft.epage=264&rft_id=info:doi/10.1038%2Fs41371-020-0330-8&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9240&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9240&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9240&client=summon |